Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab - Concepedia

Concepedia

Publication | Open Access

Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab

DOI Full Paper Access

218

Citations

16

References

2014

Year

Aidan A. Long, Abdelkader Rahmaoui, Kenneth J. Rothman, Eva C. Guinan, Mark D. Eisner, Mary S. Bradley, Carlos Iribarren, Hubert Chen, Gillis Carrigan, Karin Rosén,

Journal of Allergy and Clinical Immunology

Abstract

Results from EXCELS suggest that omalizumab therapy is not associated with an increased risk of malignancy.

References

	Year	Citations

Page 1